PFE  Pfizer Inc.




Consumer Durables


Major Pharmaceuticals

Market Cap.


Vuru Grade


Current Price

+0.025 (+0.086%)

Growth Price

Fairly valued

Stability Price

Overvalued by 58.73%

Company Metrics

  • P/E 23.37
  • P/S 3.665
  • P/B 2.679
  • EPS 1.24
  • Cash ROIC 12.30%
  • Cash Ratio 1.67
  • Dividend 1.2 / 3.98%
  • Avg. Vol. 38.55M
  • Shares 6.17B
  • Market Cap. 179.17B

Company Description

Pfizer Inc., a biopharmaceutical company, offers prescription medicines for humans and animals worldwide. The company's Biopharmaceutical segment's provides Lipitor for elevated LDL-cholesterol levels in the blood; Enbrel for rheumatoid arthritis, polyarticular juvenile rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, and ankylosing spondylitis; Lyrica for post-herpetic neuralgia, diab... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


PFIZER INC (PFE) Earnings Report: Q4 2015 Conference Call Transcript - Feb 3, 2016
The slides that will be presented on this call can be viewed on our homepage by clicking on the link for Pfizer quarterly corporate performance fourth quarter 2015 which is located in the For Investors section in the lower right hand corner ...
Why Pfizer Inc Can Surge On Q4 Earnings - Bidness ETC
Pfizer Inc. (PFE) Announces Quarterly Earnings Results - EMQ
Pfizer Inc (PFE) Closes 0.38% Down on the Day for February 05 - 1 hour ago
Dow Jones component Pfizer Inc (PFE) saw its stock move -0.38% to $28.89, representing a per-share move of $0.1114, on volume of 27.95 million shares for Friday.
Pfizer, Inc. (NYSE:PFE) News Sentiment in Limelight
Markets Daily - 3 hours ago
Alpha One has advanced algorithm supported analytics that can be used to know stock sentiment. This process works by content published on online channels.
Forget Pfizer Inc.: Here Are 2 Better Dividend Stocks
Motley Fool - Jan 26, 2016
When it comes to yield, GlaxoSmithKline beats Pfizer hands down. Glaxo's dividend yield of 5.45% ranks among the highest in the healthcare sector.
Pfizer Inc (PFE) Stock Looks GREAT (Once You Get Past the Noise!) - Feb 4, 2016
Having a tough time getting a bead on Pfizer Inc (PFE)? Don't worry - it's not you. Pfizer stock is currently a walking contradiction, catering to the bulls and the bears.
Pfizer, Inc. (PFE) Ex-Dividend Date Scheduled for February 03, 2016 - Nasdaq
Pfizer Inc. (PFE) PT Lowered to $38.00 at Credit Suisse - Intercooler Financial
Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE ...
Journal Transcript - Feb 4, 2016
To combat the menace of the Zika disease, Pfizer Inc. (NYSE:PFE), Johnson & Johnson (NYSE:JNJ), Merck & Co., Inc. (NYSE:MRK) have also joined the league of pharmaceuticals developing vaccines for the virus.
Pfizer, J&J, Merck evaluating technologies for Zika vaccine - Reuters
Can 2016 Be a New Beginning for Pfizer Inc.?
Motley Fool - Jan 7, 2016
The coming of a the new year could spell a new beginning for pharma giant Pfizer (NYSE:PFE). The acquisition of Allergan (NYSE:AGN) will mean huge tax savings for the company -- a tax rate drop from 24% to approximately 18%. In addition to the tax ...
Earnings Reaction History: Pfizer Inc, 50.0% Follow-Through Indicator, 1.8 ...
Nasdaq - Feb 2, 2016
Pfizer Inc ( PFE ) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement.
Pfizer Inc (PFE) Closes 1.77% Down on the Day for February 04 - Feb 4, 2016
Dow Jones component Pfizer Inc (PFE) saw its stock move -1.77% to $29.15, representing a per-share move of $0.525, on volume of 41.37 million shares for Thursday.
Mixed Earnings Expectations For Merck And Pfizer
Benzinga - Feb 1, 2016
Pharmaceutical giants Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) are expected to post quarterly results this week.